Importantly, mortalin knockdown did not significantly affect the proliferation of normal HaCaT cells, suggesting that mortalin is a cancer cell-specific target, which could be attributed to the cancer cell-specific mortalin-p53 interaction reported earlier [27]. The gene discussed is HSPA9; the disease is cancer.